Notably, intravenous (i.v.)administration of lipid nanoparticles containing siRNA-AR suppressed PCa cell viability and reduced serum levels of PSA to about 40% in comparison to a control mouse model [191]. The gene discussed is AR; the disease is posterior cortical atrophy.